Behrad Derakhshan, Chief Business Officer at Edgewise Therapeutics, Inc. (EWTX), sold 10,000 shares at $20.01 ($200K) on 2024-02-08, disclosed to the SEC on 2024-02-09.
Scheduled sale ($200k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 600 | $12K | 6.0% |
| 2 | $20.01 | 4,600 | $92K | 46.0% |
| 3 | $20.04 | 4,800 | $96K | 48.0% |
| Total | $20.02 avg | 10,000 | $200K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $28K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $300K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.4M | — | Filing → |